Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

In accordance with Annex VIII information on carcinogenicity is not required for a substance manufactured/imported in amounts 10-100 tons. The  substance has shown to be not genotoxic in vitro and in vivo. Therefore no genotoxic carcinogenicity is expected, via the oral, inhalation and dermal route.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Quality of whole database:
The quality of the database is adequate because the genotoxicity endpoints have been covered by adequate and reliable genotoxicity tests.

Justification for classification or non-classification

The genotoxicity of the substance has been assessed in vitro for two genotoxicity endpoints: genotoxicity in bacteria and chromosomal aberrations in CHL cells, resulting in the absence of genotoxicity. Also in an in vivo micronucleus test no effects were seen. Therefore no genotoxic carcinogenicity is expected, via the oral, inhalation and dermal route. The substance does not have to be classified for genotoxic carcinogenicity via the oral, inhalation and dermal route in accordance with the criteria outlined in Annex VI of 67/548/EEC (DSD) and Annex 1 of 1272/2008/EEC (CLP).

Additional information

Justification for selection of carcinogenicity via oral route endpoint:
For this endpoint the conclusion is based on the absence of positive results in the genotoxicity testing and therefore no genotoxic carcinogenicity is expected and the conclusion is adequate for this endpoint.